HOOKIPA PHARMA INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
HOOKIPA PHARMA INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $5.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2025-05-15
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $5.00K.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $69.00K.
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $224.00K.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $336.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2025-03-31 | $5.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $69.00K 10-K · filed 2025-02-28 |
| 2024-09-30 | $224.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $336.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $419.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $486.00K 10-K · filed 2024-03-22 |
| 2023-09-30 | $353.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $534.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $435.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $489.00K 10-K · filed 2023-03-15 |
| 2022-09-30 | $856.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.09M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.68M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.62M 10-K · filed 2022-03-24 |
| 2021-09-30 | $137.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.12M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $5.59M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $8.67M 10-K · filed 2021-03-18 |
| 2020-09-30 | $2.87M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $6.29M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $2.18M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $9.49M 10-K · filed 2020-03-19 |
| 2019-09-30 | $6.37M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $5.38M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $7.34M 10-Q · filed 2019-05-20 |